Abstract
Hansmann et al1 reported their validity assessment of a previously reported model that estimates the likelihood of safe removal of a retrievable inferior vena cava filter (rIVCF). In 2010, the Food and Drug Administration delivered safety communications stating that ongoing surveillance and management of rIVCF was the responsibility of the treating and implanting clinicians and that, once no longer needed, retrieval should be considered.2 This resulted in decreased usage of rIVCFs throughout the United States.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Vascular Surgery: Venous and Lymphatic Disorders
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
